Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment

Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment
复制标题

DOI:
10.1097/01.chi.0000128797.91601.1a
复制
发表时间:
2004-07-01
影响因子:
13.3
通讯作者:
Pollack, S
Pollack, S
中科院分区:
医学1区
文献类型:
--
作者:
Abikoff, H;Hechtman, L;Pollack, S

文献摘要

被引文献

相似文献

目的:测试哌甲酯联合强化多模式心理社会干预,包括社会技能训练,显着提高注意力缺陷多动障碍(ADHD)儿童的社会功能相比,哌甲酯单独和哌甲酯加非特异性心理社会治疗(注意力控制)。方法:103名ADHD儿童(7-9岁),无行为和学习障碍,对短期哌甲酯有反应,随机接受(1)哌甲酯单独治疗,(2)哌甲酯加多模式心理社会治疗,包括社会技能训练,或(3)哌甲酯加注意力控制治疗。评估包括家长,儿童和教师的社会功能和直接学校的观察,在体育馆的评级。结果如下:在社会功能的任何测量方面,联合治疗与哌甲酯单独治疗或哌甲酯加注意力控制相比均无优势。所有治疗均出现显著改善,并持续2年以上。结论:在患有ADHD的幼儿中,没有支持以诊所为基础的社会技能训练作为长期心理干预的一部分,以改善社会行为。哌甲酯的显著获益在2年内保持稳定。
Objective: To test that methylphenidate combined with intensive multimodal psychosocial intervention, which includes social skills training, significantly enhances social functioning in children with attention-deficit/hyperactivity disorder (ADHD) compared with methylphenidate alone and methylphenidate plus nonspecific psychosocial treatment (attention control). Method: One hundred three children with ADHD (ages 7-9), free of conduct and learning disorders, who responded to short-term methylphenidate were randomized for 2 years to receive (1) methylphenidate alone, (2) methylphenidate plus multimodal psychosocial treatment that included social skills training, or (3) methylphenidate plus attention control treatment. Assessments included parent, child, and teacher ratings of social function and direct school observations in gym. Results: No advantage was found on any measure of social functioning for the combination treatment over methylphenidate alone or methylphenidate plus attention control. Significant improvement occurred across all treatments and continued over 2 years. Conclusions: In young children with ADHD, there is no support for clinic-based social skills training as part of a long-term psychosocial intervention to improve social behavior. Significant benefits from methylphenidate were stable over 2 years.